- The New England Journal of Medicine, found all 14 patients — and counting — had no sign of cancer after receiving dostarlimab, made by the drugmaker GlaxoSmithKline, every three weeks for six months, according to a release. https://www.silive.com/news/2022/06/nyc-cancer-trial-delivers-shocking-results-remission-for-all-patients.html 49 comments worldnews
Linked pages
- Small Study on Rectal Cancer Results in Remission in Every Patient - The New York Times https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html?amp%3Bsmid=url-share&unlocked_article_code=AAAAAAAAAAAAAAAACEIPuomT1JKd6J17Vw1cRCfTTMQmqxCdw_PIxftm3iWka3DLDm4fiOQYCoyc-wDXaKF_bt921D2dT9JbdbQvSfdx1uheOVAoSg-oo5GFhJMfZSUprIb5FkUH46XwZ5Fquzn7cjv-b-5l2Ly0ux_BbGW5UKLU13I-JFtkoI9id16qxSQPxfzaE7J32Ncpja1yUp94Vi5AMHfRx4TgAx99PtyAax3OuEJhC6wCB2alzZPL4KkAcQ5SFVvCUHp7hG4349tcM9oUV73te19iIIGtxOVMVRE7aduhFJYzRIPLlrt1sLGrqRyEyMG-xv1eB7yOfx4v7aHhVOBG3l-oNZuA 2655 comments
- https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home 14 comments
Related searches:
Search whole site: site:www.silive.com
Search title: NYC cancer trial delivers shocking results: Remission for all patients - silive.com
See how to search.